Levi-Schaffer F, Barkans J, Newman T M, Ying S, Wakelin M, Hohenstein R, Barak V, Lacy P, Kay A B, Moqbel R
Department of Allergy and Clinical Immunology, National Heart and Lung Institute, London, UK.
Immunology. 1996 Jan;87(1):155-61.
Interleukin-2 (IL-2) is an essential growth factor for T cells. Previous studies have shown that human peripheral eosinophils respond to IL-2 in chemotaxis and express the IL-2 receptor (CD25). In addition, eosinophils have been shown to transcribe messenger RNA for IL-2. The aim of the present study was to determine whether eosinophils translate mRNA for IL-2 and to determine the site of intracellular localization. By immunocytochemistry, an average of 9% of cells showed cytoplasmic staining for IL-2 in freshly isolated unstimulated blood eosinophils obtained from asthmatic subjects who were not receiving oral corticosteroid treatment (n = 5). Freshly isolated, disrupted, highly purified eosinophils (> 99%, by CD16- immunomagnetic selection) contained an average of 6 pg/10(6) cells of IL-2 measured by a specific enzyme linked immunosorbent assay (ELISA) (n = 7). Purified eosinophil incubated with serum-coated Sephadex beads showed an increase in the amount of intracellularly-retained IL-2 (26.2 +/- 7.2 pg/10(6) cells) with some evidence for release of this cytokine but only in three out of six eosinophil preparations (range 1.3-5.8 pg/10(6) cells). The intracellular localization of IL-2 was determined by fractionation of the cells on a linear (0-45%) Nycodenz gradient in sucrose buffer followed by detection of IL-2 in the fractions using an IL-2-specific ELISA and dot blotting. The majority of the IL-2 detected co-eluted with known eosinophil granule markers (i.e. major basic protein (MBP), eosinophil cationic protein (ECP), eosinophil peroxidase (EPO) and beta-hexosaminidase) but small quantities were also detected in the cytosolic (lactate dehydrogenase-(LDH) associated) and membrane (CD9+) fractions. Immunogold labelling of intact eosinophils using an anti-IL-2 monoclonal antibody confirmed IL-2 immunoreactivity in association with the eosinophil crystalline granule cores. These data are consistent with the hypothesis that eosinophils synthesize, release and store IL-2 largely within cystalloid granules. This stored IL-2 may serve as a reservoir for rapid release of IL-2 in inflammatory reactions associated with eosinophilia.
白细胞介素-2(IL-2)是T细胞的一种重要生长因子。先前的研究表明,人外周血嗜酸性粒细胞对IL-2有趋化反应,并表达IL-2受体(CD25)。此外,嗜酸性粒细胞已被证明可转录IL-2的信使核糖核酸。本研究的目的是确定嗜酸性粒细胞是否翻译IL-2的信使核糖核酸,并确定细胞内定位的部位。通过免疫细胞化学方法,在从未接受口服皮质类固醇治疗的哮喘患者中获得的新鲜分离的未刺激血液嗜酸性粒细胞中,平均9%的细胞显示出IL-2的细胞质染色(n = 5)。通过特定的酶联免疫吸附测定(ELISA)测量,新鲜分离、破碎、高度纯化的嗜酸性粒细胞(通过CD16免疫磁选法,纯度> 99%)平均每10⁶个细胞含有6 pg的IL-2(n = 7)。用血清包被的葡聚糖凝胶珠孵育纯化的嗜酸性粒细胞,细胞内保留的IL-2量增加(26.2±7.2 pg/10⁶个细胞),有一些证据表明这种细胞因子会释放,但仅在六份嗜酸性粒细胞制剂中的三份中观察到释放(范围为1.3 - 5.8 pg/10⁶个细胞)。通过在蔗糖缓冲液中的线性(0 - 45%)Nycodenz梯度上对细胞进行分级分离,然后使用IL-2特异性ELISA和斑点印迹法检测各组分中的IL-2,确定了IL-2的细胞内定位。检测到的大多数IL-2与已知的嗜酸性粒细胞颗粒标志物(即主要碱性蛋白(MBP)、嗜酸性粒细胞阳离子蛋白(ECP)、嗜酸性粒细胞过氧化物酶(EPO)和β-己糖胺酶)共同洗脱,但在细胞质(与乳酸脱氢酶(LDH)相关)和膜(CD9⁺)组分中也检测到少量。使用抗IL-2单克隆抗体对完整嗜酸性粒细胞进行免疫金标记,证实IL-2免疫反应性与嗜酸性粒细胞结晶颗粒核心相关。这些数据与嗜酸性粒细胞在很大程度上在晶体样颗粒内合成、释放和储存IL-2的假设一致。这种储存的IL-2可能作为一种储备,以便在与嗜酸性粒细胞增多相关的炎症反应中快速释放IL-2。